Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Intensity Therapeutics

Explore full profile

Innovative cancer treatments targeting both visible tumors and unseen micro metastases for extended patient survival

Shelton, United StatesFounded 2012Biotech & Life Sciences
Valuation $11M Market cap · 2026

About Intensity Therapeutics

Intensity Therapeutics is a clinical-stage biotechnology company focused on developing innovative cancer treatments. Founded in 2012, the company aims to extend the lives of cancer patients while improving their quality of life. Intensity Therapeutics operates in the oncology market, targeting both visible solid tumors and unseen micro metastases, which are small cancerous cells that can spread throughout the body. The company's lead product, INT230-6, is currently undergoing human clinical trials to treat refractory solid tumor cancers. The business model revolves around the development and clinical testing of proprietary drug formulations, with revenue generated through partnerships, investments, and potential future sales of approved treatments. Intensity Therapeutics serves patients with advanced cancer, healthcare providers, and potential investors interested in supporting innovative cancer therapies.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2012
Headquarters
Shelton, United States
Listing
IPO 2023
Sector
Biotech & Life Sciences

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • VCapital
  • Batterson Venture Capital
  • Jim Mellon
  • Declan Doogan
  • SalvaRx Group PLC
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Intensity Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intensity Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.